معرفی
Lara Maxwell is a Professor of Physiological Sciences at Oklahoma State University, where she has held a faculty position since 2016. Her research bridges veterinary medicine and pharmacological sciences, with particular expertise in drug disposition and effects in various animal species.
Dr. Maxwell's research interests span veterinary pharmacology, toxicology, and physiological sciences, with specific focus on pharmacokinetics of antimicrobial agents, anesthetics, and novel compounds in equine and exotic animal models. Her work frequently examines drug concentration dynamics in neonatal foals, horses, and rabbits, addressing critical clinical questions about therapeutic dosing regimens and drug safety. She has made significant contributions to understanding amikacin pharmacokinetics in neonatal foals, bupivacaine formulations for equine analgesia, and cannabinoid metabolism in various species.
Analysis of her recent publications reveals a strong emphasis on translational veterinary pharmacology with direct clinical applications. Her research program demonstrates particular strength in equine pharmacology (35% of recent publications), forensic toxicology (25%), and exotic animal medicine (20%). The majority of her work employs rigorous pharmacokinetic modeling approaches combined with clinical outcome assessments, reflecting her dual expertise in basic pharmacological principles and clinical veterinary applications.
Dr. Maxwell actively contributes to the academic community through extensive peer review activities, having served as a reviewer for journals including Frontiers in Veterinary Science, Journal of Veterinary Pharmacology and Therapeutics, and NeuroToxicology. She also participates in multiple institutional committees, notably the Institutional Animal Care and Use Committee (2020-2023) and various examination committees.
Her research program includes collaborations with colleagues across veterinary disciplines, particularly in equine medicine and toxicology. Current projects appear focused on optimizing antimicrobial delivery in neonatal foals, evaluating novel anesthetic formulations for extended pain control, and investigating the forensic toxicology implications of cannabinoid use in animals.
